Search alternatives:
"confers increased" » "content increased" (Expand Search), "cases increased" (Expand Search), "content increases" (Expand Search)
"point decrease" » "point increase" (Expand Search)
"unit decrease" » "unit increase" (Expand Search)
Showing 61 - 80 results of 107 for search '(((("unit decrease") OR ("point decrease"))) OR ("confers increased"))', query time: 0.21s Refine Results
  1. 61
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    p<i>bla</i> mobilisation by pConj.

    p<i>bla</i> mobilisation by pConj. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    p<i>bla</i>.1 mobilisation by pConj.1 in isogenic matings.

    p<i>bla</i>.1 mobilisation by pConj.1 in isogenic matings. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    (A) Analysis of the Tn<i>2</i> deletion region: the truncation affecting <i>tnpR</i> in gonococcal p<i>bla</i>.1 and p<i>bla</i>.2 differ by a single nucleotide.

    (A) Analysis of the Tn<i>2</i> deletion region: the truncation affecting <i>tnpR</i> in gonococcal p<i>bla</i>.1 and p<i>bla</i>.2 differ by a single nucleotide. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Primers used for strain construction.

    Primers used for strain construction. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    <i>N. gonorrhoeae</i> isolates used for phylogeny.

    <i>N. gonorrhoeae</i> isolates used for phylogeny. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Examples of gonococcal p<i>bla</i> used for phylogeny.

    Examples of gonococcal p<i>bla</i> used for phylogeny. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Minimum spanning trees of <i>N. gonorrhoeae</i> clustered by core genome allelic differences using Grapetree [65] with distribution of p<i>bla</i> variants.

    Minimum spanning trees of <i>N. gonorrhoeae</i> clustered by core genome allelic differences using Grapetree [65] with distribution of p<i>bla</i> variants. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    The percentage of isolates carrying p<i>bla</i> in three largest Ng_cgc400 that carry each variant.

    The percentage of isolates carrying p<i>bla</i> in three largest Ng_cgc400 that carry each variant. by Tabea A. Elsener (21253459)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: